Fonte: Archives of Drug Information. Unidade: FMRP
Assunto: PSORÍASE (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKAHASHI, Maria Denise Fonseca et al. Efalizumab in the treatment of scalp, palmoplantar and nail psoriasis: results of a 24-week Latin American Study. Archives of Drug Information, v. 3, n. 1, p. 1-18, 2010Tradução . . Acesso em: 08 nov. 2024.APA
Takahashi, M. D. F., Chouela, E. N., Dorantes, G. L., Roselino, A. M. F., Santamaria, J., Allevato, M. A., et al. (2010). Efalizumab in the treatment of scalp, palmoplantar and nail psoriasis: results of a 24-week Latin American Study. Archives of Drug Information, 3( 1), 1-18.NLM
Takahashi MDF, Chouela EN, Dorantes GL, Roselino AMF, Santamaria J, Allevato MA, Cestari T, Aillaud MEM de, Stengel FM, Licu D. Efalizumab in the treatment of scalp, palmoplantar and nail psoriasis: results of a 24-week Latin American Study. Archives of Drug Information. 2010 ; 3( 1): 1-18.[citado 2024 nov. 08 ]Vancouver
Takahashi MDF, Chouela EN, Dorantes GL, Roselino AMF, Santamaria J, Allevato MA, Cestari T, Aillaud MEM de, Stengel FM, Licu D. Efalizumab in the treatment of scalp, palmoplantar and nail psoriasis: results of a 24-week Latin American Study. Archives of Drug Information. 2010 ; 3( 1): 1-18.[citado 2024 nov. 08 ]
